
29/07/2025
At VINNO Ultrasound, we are proud to power the newly launched ๐๐ซ๐จ๐ฌ๐ฉ๐๐๐ญ๐ข๐ฏ๐ ๐๐ฎ๐ฅ๐ญ๐ข๐๐๐ง๐ญ๐๐ซ ๐๐ญ๐ฎ๐๐ฒ ๐จ๐ง ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐๐ฉ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฎ๐ฉ๐๐ซ-๐๐๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ข๐๐ซ๐จ๐ฌ๐๐จ๐ฉ๐ฒ ๐๐ฆ๐๐ ๐ข๐ง๐ , led by Jiangsu Provincial Peopleโs Hospital with 11 top hospitals.
With over 120 million people affected by Chronic Kidney Disease (CKD) in China, early and accurate diagnosis is critical. Our cutting-edge Ultra-Resolution Microscopy ( ) technology delivers ๐ฮผ๐ฆ-๐ฅ๐๐ฏ๐๐ฅ renal microvascular imaging, providing a revolutionary path for safe, noninvasive, and precise early detection.
๐ท ๐๐ฎ๐ข๐จ๐ฆ: ๐๐ต๐ข๐จ๐ฆ 3 ๐๐ฉ๐ณ๐ฐ๐ฏ๐ช๐ค ๐๐ฆ๐ฑ๐ฉ๐ณ๐ช๐ต๐ช๐ด โ ๐๐ฆ๐ง๐ต ๐๐ช๐ฅ๐ฏ๐ฆ๐บ ๐๐๐ ๐๐ญ๐ฐ๐ฎ๐ฆ๐ณ๐ถ๐ญ๐ข๐ณ ๐๐ข๐ฑ, ๐ท๐ช๐ด๐ถ๐ข๐ญ๐ช๐ป๐ช๐ฏ๐จ ๐จ๐ญ๐ฐ๐ฎ๐ฆ๐ณ๐ถ๐ญ๐ข๐ณ ๐ฎ๐ช๐ค๐ณ๐ฐ๐ท๐ข๐ด๐ค๐ถ๐ญ๐ข๐ต๐ถ๐ณ๐ฆ ๐ง๐ฐ๐ณ ๐ฆ๐ข๐ณ๐ญ๐บ ๐๐๐ ๐ข๐ด๐ด๐ฆ๐ด๐ด๐ฎ๐ฆ๐ฏ๐ต.
Hosting multiple multicenter studies worldwide, VINNO continues to drive innovation and reshape the future of kidney care โ from late-stage treatment to proactive early intervention. ๐
๐ Stay tuned as we share impactful case studies from this research.